BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Due to a website maintenance error, a draft of a letter to BioAdaptives® (OTC: BDPT) shareholders was made available on the BioAdaptives® website.

Cash generation is up 4% compared to September 2023, and net debt has fallen 89 million in the past year - Subscription models continue to drive growth and digital transformation: Santillana reports ...

Amongst the first Indian-American picks by US President-elect Donald Trump is biotech entrepreneur Vivek Ramaswamy, who has ...

German drugmaker to use state-of-art antibody in tandem with advanced therapies to more effectively fight cancer, detect ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Ramaswamy is now part of Donald Trump’s future Department of Government Efficiency. Learn how he made his fortune and where ...

The London Company, an investment management company, released “The London Company Small Cap Strategy” third quarter 2024 ...

COLUMBUS, Ohio—Ohio biotech entrepreneur Vivek Ramaswamy has been named by President-elect Donald Trump to co-run a new “Department of Government Efficiency,” a move he says removes him from being ...

TRexBio secured $84 million Series B funding, led by Delos Capital with Eli Lilly and Johnson & Johnson participating, to ...

Elon Musk and Vivek Ramaswamy will lead Trump’s DOGE agency to overhaul federal bureaucracy and reduce wasteful spending.

Hera Biotech’s cofounders from left to right: Dr. Bruce Nicholson, Dr. Paul Castella, Somer Baburek, ... [+] & Dr Nameer ...